Figure 1.
Subgroup analysis of anticonvulsant medications showing the proportion of patients with a clinically meaningful response to treatment versus placebo: A) Pregabalin; B) gabapentin; C) oxcarbazepine; and D) topiramate.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.